ESTRO 2020 Abstract Book

Debate This house believes that there is no future for adaptive radiotherapy in EBRT without an MR-linac....... (Abs. 629-632) Proffered Papers Proffered papers 33.2: Dosimetry and QA....................................................................................................... (Abs. 633-638) Symposium Challenging cancers........................................................................................................................................... (Abs. 639-641) How to become a department head. ............................................................................................................... (Abs. 642-646) Poster Highlights Poster highlights 21 PH: Predictive modelling................................................................................................. (Abs. 647-653) Poster discussion CL: Gynaecology. ................................................................................................................................................ (Abs. 654-659) CL: Head and neck 2........................................................................................................................................... (Abs. 660-665) CL: Prostate 2...................................................................................................................................................... (Abs. 666-671) RTT 2.................................................................................................................................................................... (Abs. 672-677) Award Lecture K. Breur Award Lecture..............................................................................................................................................(Abs. 678) Donal Hollywood Award............................................................................................................................................(Abs. 679) Proffered Papers Proffered papers 33.1: Image guided radiotherapy. ...................................................................................... (Abs. 680-685) Proffered papers 34: Particle therapy in CNS tumours.................................................................................. (Abs. 686-691) Proffered papers 35 : Late-breaking abstracts................................................................................................ (Abs. 692-696) Proffered papers 36 - Managing uncertainties in proton therapy................................................................ (Abs. 697-702) Proffered papers 37: 4D and Adaptive RT........................................................................................................ (Abs. 703-708) Proffered papers 38: Current status of MR guided RT................................................................................... (Abs. 709-714) Poster Highlights Poster highlights 22 PH: Outcome modelling.................................................................................................. (Abs. 715-721) Teaching Lecture Spatially fractionated GRID radiotherapy - rationale and promise.......................................................................(Abs. 722) Noninvasive cardiac radioablation for ventricular tachycardia.............................................................................(Abs. 723) Is it safe to treat central lung lesions with SBRT?....................................................................................................(Abs. 724) Sexual rehabilitation and management of sexual problems after treatment for pelvic cancer................ (Abs. 725-726) Dosimetry and QA for MR-Linacs..............................................................................................................................(Abs. 727) Overview of micro/nanodosimetry and application to particle beams................................................................(Abs. 728) Real time adpative radiotherapy with MRlinac........................................................................................................(Abs. 729) Symposium The latest news on FLASH: ultra-high dose rate radiotherapy...................................................................... (Abs. 730-732) Dose accumulation and re-irradiation for thoracic malignancies................................................................. (Abs. 733-736) Multimodal approaches to oligometastatic disease: state-of-the-art in NSCLC.......................................... (Abs. 737-740) Joint Debate ESTRO-ESGO: This house believes that lymph node dissection can be omitted in FIGO stage IB1/2(<4 cm)iN1(imaging) cervical cancer................................................................................ (Abs. 741-744) Symposium Quo-vadis log file based QA for adaptive radiotherapy?................................................................................ (Abs. 745-747) PBT planning: lessons learned.......................................................................................................................... (Abs. 748-750) Innovations in radiotherapy.............................................................................................................................. (Abs. 751-753) Ultra-hypofractionation for localised prostate cancer................................................................................... (Abs. 754-757) Joint Symposium ESTRO-IASLC: Combined radiotherapy and immunotherapy in NSCLC........................................................ (Abs. 758-761)

TUESDAY 1 DECEMBER 2020